Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Daniel A, Spyker"'
Autor:
David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, P. T. Pham Nathaniel, Alvin C. Bronstein, Julie A. Weber
Publikováno v:
Clinical Toxicology. 60:1381-1643
Publikováno v:
Clinical Toxicology. 60:1113-1121
The introduction of delayed release formulations of acetaminophen (APAP) has created concern about the role of formulation in overdose. We examined the APAP overdose pharmacokinetic (PK) profiles to assess the role of dose, coingestants and formulati
Publikováno v:
BJPsych Open, Vol 3, Pp 285-290 (2017)
Background Efficacy of inhaled loxapine 5 or 10 mg in treating agitation was shown using the Positive and Negative Syndrome Scale – Excited Component (PANSS-EC) in two Phase III randomised, double-blind, placebo-controlled trials in 344 agitated p
Externí odkaz:
https://doaj.org/article/6badc39d965b45a5ac3181c15e9dc614
Autor:
David D, Gummin, James B, Mowry, Michael C, Beuhler, Daniel A, Spyker, Alvin C, Bronstein, Laura J, Rivers, Nathaniel P T, Pham, Julie, Weber
Publikováno v:
Clinical Toxicology. 59:1282-1501
This is the 38We analyzed the case data tabulating specific indices from NPDS. The methodology was similar to that of previous years. Where changes were introduced, the differences are identified. Cases with medical outcomes of death were evaluated b
Autor:
Chris DeWitt, Marco L.A. Sivilotti, Elizabeth Haney, Margaret Thompson, David W. Johnson, Charlemagne Victorino, Sophie Gosselin, Jason A Lord, Barry H. Rumack, Benoit Bailey, Daniel A. Spyker, Roy Purssell, Nancy G. Murphy, Kathryn Dong, Alberto Nettel-Aguirre, Mark Yarema
Publikováno v:
British Journal of Clinical Pharmacology. 87:3332-3343
Aims Early identification of patients likely to die after acetaminophen (APAP) poisoning remains challenging. We sought to compare the sensitivity and time to fulfilment (latency) of established prognostic criteria. Methods Three physician toxicologi
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 60(1)
Objectives Our six goals are: 1) describe the relationship between the National Strategy for the COVID-19 Response and Pandemic Preparedness and the 55 US poison centers (PCs); 2) detail FDA emergency Use Authorization (EUA) COVID-19 vaccine-related
Publikováno v:
Breastfeeding Medicine. 14:508-512
Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data Syste...
Autor:
Mark C Yarema, Daniel A. Spyker, David W Johnson, Jason P Green, Adam Mutsaers, Marco L.A. Sivilotti, Dylan Tucker, Barry H. Rumack
Publikováno v:
Clinical Toxicology. 57:380-386
The Rumack-Matthew nomogram stratifies patients into discrete risk zones following acetaminophen (APAP) overdose. Treatment decisions have traditionally been based on the initial risk zone. "Line-crossing" between zones occurs and is poorly understoo
Autor:
James B. Mowry, William Banner, Krista M Osterthaler, Daniel E. Brooks, David D Gummin, Daniel A. Spyker
Publikováno v:
Clinical Toxicology. 56:1213-1415
Introduction: This is the 35th Annual Report of the American Association of Poison Control Centers’ (AAPCC) National Poison Data System (NPDS). As of 1 January 2017, 55 of the nation’s poison cente...
Autor:
James B. Mowry, Daniel E. Brooks, Michael C. Beuhler, Nathaniel P T Pham, Mark L Ryan, Daniel A. Spyker, Katherine W Dibert, Laura J Rivers, David D Gummin
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 58(12)
Introduction: This is the 37th Annual Report of the American Association of Poison Control Centers' (AAPCC) National Poison Data System (NPDS). As of 1 January, 2019, all 55 of the nation's poison centers (PCs) uploaded case data automatically to NPD